The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Spinal Muscular Atrophy Genetic Detection Market Research Report 2025
Synopsis
A detection method for Spinal Muscular Atrophy
The global Spinal Muscular Atrophy Genetic Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Spinal Muscular Atrophy Genetic Detection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Spinal Muscular Atrophy Genetic Detection include United Gene Group, Berrygenomics, Sanvalley, Microread and Genecore, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy Genetic Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy Genetic Detection.
Report Scope
The Spinal Muscular Atrophy Genetic Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spinal Muscular Atrophy Genetic Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spinal Muscular Atrophy Genetic Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Gene Group
Berrygenomics
Sanvalley
Microread
Genecore
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
A detection method for Spinal Muscular Atrophy
The global Spinal Muscular Atrophy Genetic Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Spinal Muscular Atrophy Genetic Detection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Spinal Muscular Atrophy Genetic Detection in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Spinal Muscular Atrophy Genetic Detection include United Gene Group, Berrygenomics, Sanvalley, Microread and Genecore, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Spinal Muscular Atrophy Genetic Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Spinal Muscular Atrophy Genetic Detection.
Report Scope
The Spinal Muscular Atrophy Genetic Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Spinal Muscular Atrophy Genetic Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Spinal Muscular Atrophy Genetic Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
United Gene Group
Berrygenomics
Sanvalley
Microread
Genecore
Segment by Type
Genetic Screening
Reproductive Genetic Testing
Diagnostic Test
Gene carrier Test
Testing Before Symptoms Appear
Segment by Application
Hospital
Clinic
Diagnostic Center
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Spinal Muscular Atrophy Genetic Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Genetic Screening
1.2.3 Reproductive Genetic Testing
1.2.4 Diagnostic Test
1.2.5 Gene carrier Test
1.2.6 Testing Before Symptoms Appear
1.3 Market by Application
1.3.1 Global Spinal Muscular Atrophy Genetic Detection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Diagnostic Center
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Spinal Muscular Atrophy Genetic Detection Market Perspective (2019-2030)
2.2 Spinal Muscular Atrophy Genetic Detection Growth Trends by Region
2.2.1 Global Spinal Muscular Atrophy Genetic Detection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Spinal Muscular Atrophy Genetic Detection Historic Market Size by Region (2019-2024)
2.2.3 Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Region (2025-2030)
2.3 Spinal Muscular Atrophy Genetic Detection Market Dynamics
2.3.1 Spinal Muscular Atrophy Genetic Detection Industry Trends
2.3.2 Spinal Muscular Atrophy Genetic Detection Market Drivers
2.3.3 Spinal Muscular Atrophy Genetic Detection Market Challenges
2.3.4 Spinal Muscular Atrophy Genetic Detection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue
3.1.1 Global Top Spinal Muscular Atrophy Genetic Detection Players by Revenue (2019-2024)
3.1.2 Global Spinal Muscular Atrophy Genetic Detection Revenue Market Share by Players (2019-2024)
3.2 Global Spinal Muscular Atrophy Genetic Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Spinal Muscular Atrophy Genetic Detection Revenue
3.4 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio
3.4.1 Global Spinal Muscular Atrophy Genetic Detection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Spinal Muscular Atrophy Genetic Detection Revenue in 2023
3.5 Spinal Muscular Atrophy Genetic Detection Key Players Head office and Area Served
3.6 Key Players Spinal Muscular Atrophy Genetic Detection Product Solution and Service
3.7 Date of Enter into Spinal Muscular Atrophy Genetic Detection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Type
4.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Type (2019-2024)
4.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Type (2025-2030)
5 Spinal Muscular Atrophy Genetic Detection Breakdown Data by Application
5.1 Global Spinal Muscular Atrophy Genetic Detection Historic Market Size by Application (2019-2024)
5.2 Global Spinal Muscular Atrophy Genetic Detection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Spinal Muscular Atrophy Genetic Detection Market Size (2019-2030)
6.2 North America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2019-2024)
6.4 North America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Spinal Muscular Atrophy Genetic Detection Market Size (2019-2030)
7.2 Europe Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2019-2024)
7.4 Europe Spinal Muscular Atrophy Genetic Detection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size (2019-2030)
8.2 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2019-2024)
8.4 Asia-Pacific Spinal Muscular Atrophy Genetic Detection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Spinal Muscular Atrophy Genetic Detection Market Size (2019-2030)
9.2 Latin America Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2019-2024)
9.4 Latin America Spinal Muscular Atrophy Genetic Detection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size (2019-2030)
10.2 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2019-2024)
10.4 Middle East & Africa Spinal Muscular Atrophy Genetic Detection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 United Gene Group
11.1.1 United Gene Group Company Detail
11.1.2 United Gene Group Business Overview
11.1.3 United Gene Group Spinal Muscular Atrophy Genetic Detection Introduction
11.1.4 United Gene Group Revenue in Spinal Muscular Atrophy Genetic Detection Business (2019-2024)
11.1.5 United Gene Group Recent Development
11.2 Berrygenomics
11.2.1 Berrygenomics Company Detail
11.2.2 Berrygenomics Business Overview
11.2.3 Berrygenomics Spinal Muscular Atrophy Genetic Detection Introduction
11.2.4 Berrygenomics Revenue in Spinal Muscular Atrophy Genetic Detection Business (2019-2024)
11.2.5 Berrygenomics Recent Development
11.3 Sanvalley
11.3.1 Sanvalley Company Detail
11.3.2 Sanvalley Business Overview
11.3.3 Sanvalley Spinal Muscular Atrophy Genetic Detection Introduction
11.3.4 Sanvalley Revenue in Spinal Muscular Atrophy Genetic Detection Business (2019-2024)
11.3.5 Sanvalley Recent Development
11.4 Microread
11.4.1 Microread Company Detail
11.4.2 Microread Business Overview
11.4.3 Microread Spinal Muscular Atrophy Genetic Detection Introduction
11.4.4 Microread Revenue in Spinal Muscular Atrophy Genetic Detection Business (2019-2024)
11.4.5 Microread Recent Development
11.5 Genecore
11.5.1 Genecore Company Detail
11.5.2 Genecore Business Overview
11.5.3 Genecore Spinal Muscular Atrophy Genetic Detection Introduction
11.5.4 Genecore Revenue in Spinal Muscular Atrophy Genetic Detection Business (2019-2024)
11.5.5 Genecore Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
